Category: Tweets

CLSA "sell" report on Biocon is illogical n reflects poor understanding of huge opp for Biosimilars Axis has a "Buy" on Biocon on same .

— Kiran Mazumdar Shaw (@kiranshaw) January 6, 2016

@ashurathi and I don't like analysts like you who report without bothering to understand our business model

— Kiran Mazumdar Shaw (@kiranshaw) January 6, 2016

@kiranshaw quite obvious that according to you only those analysts who are talking +ve on ur co. understand the business model. Right?

— Ashish Rathi (@ashurathi) January 6, 2016

@ashurathi yes u got it!

— Kiran Mazumdar Shaw (@kiranshaw) January 6, 2016

Interesting day – Lots of stocks with crazy debt / cdr / defaulters were up today 52 wk highs and the #banks who funded them at 52 wk lows

— Nooresh Merani (@nooreshtech) January 5, 2016

☃ CMIE Dec quarter report sends a chill down policy corridors. New investment proposals fall 74% & commissioning of projects drops 49%.

— Vinayak Chatterjee (@Infra_VinayakCh) January 5, 2016

Fund manager: we take a longer term view on the stock market despite the sell-off How long? More than a day.

— Sid Verma (@_SidVerma) January 4, 2016